Q-Line Biotec SME IPO
ListedNSE SMEOpens 21 May 2026Closes 25 May 2026
Q-Line Biotech Limited, incorporated in 2010 (originally as POCT Services Private Limited), is an Indian diagnostics and in-vitro diagnostics (IVD) enterprise. The company is actively engaged in developing,…
Q-Line Biotech Limited, incorporated in 2010 (originally as POCT Services Private Limited), is an Indian diagnostics and in-vitro diagnostics (IVD) enterprise. The company is actively engaged in developing, manufacturing, and marketing a diverse range of medical reagents, consumable testing kits, point-of-care (POC) devices, and automated pathology equipment. Serving diagnostic laboratories, hospitals, and medical colleges directly and through an expansive national distributor network since 2013, its operational capabilities span fields like Clinical Chemistry, Haematology, Immunodiagnostics, and Molecular Diagnostics.
Show moreShow less
Key ratios
As per RHP / filingsTimeline
IPO Opens
21 May
IPO Closes
25 May
Allotment
26 May
Listing
29 May
IPO Timeline & Listing Details
| Event | Date |
|---|---|
| IPO Open Date | 21 May 2026 |
| IPO Close Date | 25 May 2026 |
| Allotment Date | 26 May 2026 |
| Listing Date | 29 May 2026 |
Investment Categories
| Category | Lots | Amount |
|---|---|---|
Individual | 2 | ₹2,74,400 |
SHNI (Min) | 3 | ₹4,11,600 |
SHNI (Max) | 7 | ₹9,60,400 |
BHNIAbove ₹10,00,000 | 8 | ₹10,97,600 |
IPO Reservation Details
| Category | Reservation |
|---|---|
| QIB (Qualified Institutional Buyer) | 49.99% |
| NII (Non-Institutional Investor) | 15.01% |
| Retail | 35.00% |
| Market Maker | 5.01% |
| Total | 100.00% |
IPO Objectives
- To meet the working capital requirements of the company (₹93.50 Cr).
- Full or partial repayment or prepayment of certain outstanding borrowings availed by the company (₹90.00 Cr).
- General Corporate Purposes.
Strengths
- The company features an In-House R&D Stack with deep technical expertise focused on domestic reverse engineering, new tool layout, and rigorous quality verification pipelines.
- It commands a Comprehensive IVD Reach through a diverse, multi-tier product catalog tailored to the fast-growing, multi-billion dollar in-vitro diagnostics industry.
- The business leverages a Widespread Distribution Framework with operational footprints firmly anchored across all four core geomorphic zones of the Indian market.
- It maintains a Stable Customer Footprint built on long-standing contractual relations with core medical service groups, premium clinical networks, and medical universities.
Weaknesses
- The company faces Capital Pipeline Stress due to a heavy internal structural dependency on working capital cycles, with ₹93.50 Cr of fresh money deployed explicitly for operating lines.
- It exhibits High Leverage Ratios, carrying a significant leverage profile with total debts building up to ₹243.85 Cr by December 2025, which heavily eats into overall capital flexibility.
- The business shows a critical Net Worth Degradation, with reported net worth slipping to -₹0.04 Cr in the latest 9M period ending December 2025, flagging severe short-term balance sheet risks.
- It operates in a highly Fragmented Marketplace, dealing with deep, localized sector rivalry from unorganized local manufacturers alongside well-capitalized multi-national healthcare corporations.
Financial Performance
| Period Ended | 31 Dec 2025 (9M) | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets (₹ Cr.) | 561.34 | 455.49 | 339.25 | 251.58 |
| Revenue (₹ Cr.) | 236.5 | 322.58 | 206.45 | 184.81 |
| PAT (₹ Cr.) | 38.69 | 28.13 | 34.44 | 32.1 |
| Net Worth (₹ Cr.) | -0.04 | 189.95 | 161.81 | 127.37 |
Peer Comparison
| Company | P/B Ratio | P/E Ratio | RONW (%) | Net Worth (₹ Cr.) |
|---|
Subscription Details
Daily Bids Status
| Category | Day 1 | Day 2 | Day 3 |
|---|---|---|---|
| QIB | 4.15x | 5.19x | 123.94x |
| NII | 5.26x | 15.62x | 145.98x |
| S-HNI | 4.08x | 10.95x | 81.35x |
| B-HNI | 5.85x | 17.96x | 178.29x |
| RII | 3.71x | 10.07x | 71.44x |
| Total | 4.17x | 9.87x | 102.42x |
Overall Subscription Statistics
| Category | Shares Offered | Shares Bid | Bid Amount (₹ Cr) |
|---|---|---|---|
| QIB | 11,88,000 | 14,72,37,200 | 5,050.24 |
| NII | 8,91,600 | 13,01,53,600 | 4,464.27 |
| Small NII | 2,97,200 | 2,41,77,600 | 829.29 |
| Big NII | 5,94,400 | 10,59,76,000 | 3,634.98 |
| RII | 20,79,200 | 14,85,32,800 | 5,094.68 |
| Total | 41,58,800 | 42,59,23,600 | 14,609.18 |
Company Details
- Q-Line Biotech Ltd.
- 298-281, Transport Nagar, Kanpur Road, Adjacent Transport Nagar Metro Station, Lucknow, Uttar Pradesh, 226012
- +91 522-2435570
- compliance@qlinebiotech.com
- https://www.qlinebiotech.com/
Registrar Details
- Purva Sharegistry (India) Pvt.Ltd.
- +91 22 4961 4132
- support@purvashare.com
- https://www.purvashare.com/
Frequently Asked Questions
What does Q-Line Biotech do?
What are the IPO dates for Q-Line Biotech SME IPO?
What is the price band and minimum investment for Q-Line Biotech IPO?
What is the Grey Market Premium (GMP) of Q-Line Biotech IPO today?
Where will Q-Line Biotech IPO be listed?
Q-Line Biotec SME IPO News & Updates
Follow the latest updates for Q-Line Biotec SME IPO, including grey market moves and allotment news.
Q-Line Biotec SME IPO IPO Pages
Open related pages for this IPO: details, GMP, subscription, allotment, review, FAQ, registrar, timeline, and news.
Q-Line Biotec SME IPO Details
Issue size, price, financials, and company info
Q-Line Biotec SME IPO GMP
Live grey market premium and listing estimate
Q-Line Biotec SME IPO Subscription
QIB, NII, Retail, SHNI and BHNI subscription
Q-Line Biotec SME IPO Allotment
Allotment date, chances, and check by PAN
Q-Line Biotec SME IPO Review
SWOT, strengths, risks, and IPO review
Q-Line Biotec SME IPO FAQ
Common questions on dates, GMP, and allotment
Q-Line Biotec SME IPO Registrar
Registrar website and how to check allotment
Q-Line Biotec SME IPO Timeline
Open, close, allotment, and listing dates
Q-Line Biotec SME IPO News
Updates, blogs, and latest IPO news
Sources
We match Q-Line Biotec SME IPO IPO numbers with official sources. For final dates and allotment results, double-check the registrar or exchange.
- SEBIRules for IPO allotment and disclosures in India
- NSEExchange notices, bidding data, and listing updates
- BSEExchange notices and IPO allotment check tools
- RHP / Offer DocumentCheck the company RHP on NSE/BSE or the IPO detail page
- Purva Sharegistry (India) Pvt.Ltd.Official site to check allotment status for this IPO
Also read our Editorial Policy, How GMP is calculated, How allotment chances work, and IPO fund allocation.
Reviewed by
Dinesh Agrawal · Lead IPO Analyst
15+ years in Indian markets and IPO research. He reviews IPO dates and key details before they go live.